DK4171563T3 - Tetrazolderivater som trpa1-hæmmere - Google Patents
Tetrazolderivater som trpa1-hæmmereInfo
- Publication number
- DK4171563T3 DK4171563T3 DK21735303.6T DK21735303T DK4171563T3 DK 4171563 T3 DK4171563 T3 DK 4171563T3 DK 21735303 T DK21735303 T DK 21735303T DK 4171563 T3 DK4171563 T3 DK 4171563T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetrazole derivatives
- trpa1 inhibitors
- trpa1
- inhibitors
- tetrazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20182988 | 2020-06-29 | ||
| PCT/EP2021/067470 WO2022002782A1 (en) | 2020-06-29 | 2021-06-25 | Tetrazole derivatives as trpa1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4171563T3 true DK4171563T3 (da) | 2025-10-20 |
Family
ID=71401656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21735303.6T DK4171563T3 (da) | 2020-06-29 | 2021-06-25 | Tetrazolderivater som trpa1-hæmmere |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US11884652B2 (da) |
| EP (1) | EP4171563B1 (da) |
| JP (1) | JP7539501B2 (da) |
| CN (3) | CN121159510A (da) |
| AR (1) | AR122779A1 (da) |
| AU (1) | AU2021298800B2 (da) |
| CA (1) | CA3181350A1 (da) |
| CL (1) | CL2022003329A1 (da) |
| CO (1) | CO2022016755A2 (da) |
| CR (1) | CR20220667A (da) |
| DK (1) | DK4171563T3 (da) |
| DO (1) | DOP2022000262A (da) |
| EC (1) | ECSP22088664A (da) |
| ES (1) | ES3049803T3 (da) |
| FI (1) | FI4171563T3 (da) |
| HR (1) | HRP20251260T1 (da) |
| HU (1) | HUE073295T2 (da) |
| IL (1) | IL299175A (da) |
| JO (1) | JOP20220350A1 (da) |
| LT (1) | LT4171563T (da) |
| MA (1) | MA60100B1 (da) |
| MX (1) | MX2022016357A (da) |
| PE (1) | PE20231852A1 (da) |
| PL (1) | PL4171563T3 (da) |
| PT (1) | PT4171563T (da) |
| RS (1) | RS67325B1 (da) |
| SA (1) | SA522441965B1 (da) |
| SI (1) | SI4171563T1 (da) |
| TW (1) | TWI907452B (da) |
| WO (1) | WO2022002782A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL306065A (en) | 2021-04-14 | 2023-11-01 | Boehringer Ingelheim Int | Uracil history as TRPA1 inhibitors |
| US20250136587A1 (en) * | 2022-02-03 | 2025-05-01 | D. E. Shaw Research, Llc | N3-substituted uracil compounds as trpa1 inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7361654B2 (en) | 2005-01-13 | 2008-04-22 | Bristol-Myers Squibb Co. | Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| JP2011231015A (ja) * | 2008-08-29 | 2011-11-17 | Taiho Yakuhin Kogyo Kk | 含窒素複素環を有する新規ウラシル化合物又はその塩 |
| WO2017060488A1 (en) | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
| JP7171567B2 (ja) * | 2016-11-28 | 2022-11-15 | エフ．ホフマン－ラ ロシュ アーゲー | 一過性受容体電位型チャネル阻害剤としてのオキサジアゾロン類 |
| IL306065A (en) | 2021-04-14 | 2023-11-01 | Boehringer Ingelheim Int | Uracil history as TRPA1 inhibitors |
-
2021
- 2021-06-24 US US17/356,748 patent/US11884652B2/en active Active
- 2021-06-25 PL PL21735303.6T patent/PL4171563T3/pl unknown
- 2021-06-25 ES ES21735303T patent/ES3049803T3/es active Active
- 2021-06-25 EP EP21735303.6A patent/EP4171563B1/en active Active
- 2021-06-25 CN CN202511215812.2A patent/CN121159510A/zh active Pending
- 2021-06-25 CN CN202511215814.1A patent/CN121085901A/zh active Pending
- 2021-06-25 PE PE2022003065A patent/PE20231852A1/es unknown
- 2021-06-25 LT LTEPPCT/EP2021/067470T patent/LT4171563T/lt unknown
- 2021-06-25 CN CN202180045969.9A patent/CN115803029B/zh active Active
- 2021-06-25 DK DK21735303.6T patent/DK4171563T3/da active
- 2021-06-25 AU AU2021298800A patent/AU2021298800B2/en active Active
- 2021-06-25 RS RS20251037A patent/RS67325B1/sr unknown
- 2021-06-25 JP JP2022578729A patent/JP7539501B2/ja active Active
- 2021-06-25 CR CR20220667A patent/CR20220667A/es unknown
- 2021-06-25 CA CA3181350A patent/CA3181350A1/en active Pending
- 2021-06-25 WO PCT/EP2021/067470 patent/WO2022002782A1/en not_active Ceased
- 2021-06-25 PT PT217353036T patent/PT4171563T/pt unknown
- 2021-06-25 FI FIEP21735303.6T patent/FI4171563T3/fi active
- 2021-06-25 MX MX2022016357A patent/MX2022016357A/es unknown
- 2021-06-25 MA MA60100A patent/MA60100B1/fr unknown
- 2021-06-25 SI SI202130357T patent/SI4171563T1/sl unknown
- 2021-06-25 HU HUE21735303A patent/HUE073295T2/hu unknown
- 2021-06-25 IL IL299175A patent/IL299175A/en unknown
- 2021-06-25 HR HRP20251260TT patent/HRP20251260T1/hr unknown
- 2021-06-28 TW TW110123608A patent/TWI907452B/zh active
- 2021-06-28 AR ARP210101795A patent/AR122779A1/es unknown
-
2022
- 2022-11-21 EC ECSENADI202288664A patent/ECSP22088664A/es unknown
- 2022-11-22 DO DO2022000262A patent/DOP2022000262A/es unknown
- 2022-11-22 CO CONC2022/0016755A patent/CO2022016755A2/es unknown
- 2022-11-25 CL CL2022003329A patent/CL2022003329A1/es unknown
- 2022-12-26 JO JOJO/P/2022/0350A patent/JOP20220350A1/ar unknown
- 2022-12-29 SA SA522441965A patent/SA522441965B1/ar unknown
-
2023
- 2023-12-05 US US18/529,485 patent/US20250092019A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4216951A4 (en) | KRAS G12D INHIBITORS | |
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| PL4214202T3 (pl) | Stałe postacie inhibitora CDK4 | |
| DK4063364T3 (da) | Pyrrolotriazinforbindelse fungerende som mnk-inhibitor | |
| DK4139286T3 (da) | Substituerede aminothiazoler som dgkzeta-hæmmere til immunaktivering | |
| DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
| DK4337652T3 (da) | NLRP3-hæmmere | |
| DK3870574T3 (da) | Aminopyridin/pyrazinderivater som ctps1-inhibitorer | |
| DK3952995T3 (da) | Bicykliske heteroarylderivater som ectonukleotidpyrophosphatase-phosphodiesterase-1-hæmmere | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| DK4182308T3 (da) | Pyridazinylamino-derivater som ALK5-inhibitorer | |
| EP4744661A2 (en) | NEW PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES | |
| DK4228755T3 (da) | Tetrazol-derivater som trpa1-hæmmere | |
| DK3700907T3 (da) | Hidtil ukendte pyrazolo-pyrrolo-pyrimidindion-derivater som p2x3-inhibitorer | |
| PL4301748T3 (pl) | Triazolilo-metylo podstawione pochodne alfa-d-galaktopiranozydu | |
| EP4149629C0 (en) | PURINE DERIVATIVES AS SIK-3 INHIBITORS | |
| DK4229056T3 (da) | Triazolpyridinylforbindelser som kinasehæmmere | |
| DK3890828T3 (da) | Heteroaromatiske forbindelser som vanin-hæmmere | |
| EP4247372A4 (en) | PLASMA KALLICREIN INHIBITORS | |
| DK4396183T3 (da) | Substituerede s-alaninatderivater | |
| DK4171571T3 (da) | Tetrazolderivater som trpa1-hæmmere | |
| EP4281457A4 (en) | PYRIDOPYRIMIDINE DERIVATIVES AS KRAS INHIBITORS | |
| EP4308572C0 (en) | NEW THIENOPYRIMIDINONE DERIVATIVES | |
| EP4210694A4 (en) | PLASMA KALLICREIN INHIBITORS | |
| MA52891A (fr) | Dérivés aza-indoliques utilisés comme inhibiteurs de rho-kinase |